Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma von LEONARD, John P, COLEMAN, Morton, GAYKO, Urte, CESANO, Alessandra, GOLDENBERG, David M, KETAS, Jamie C, CHADBURN, Amy, ELY, Scott, FURMAN, Richard R, WEGENER, William A, HANSEN, Hans J, ZICCARDI, Heather, ESCHENBERG, Michael

Volltext

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: Phase I/II clinical trial results von LEONARD, John P, COLEMAN, Morton, HANSEN, Hans J, ZICCARDI, Heather, ESCHENBERG, Michael, GAYKO, Urte, FIELDS, Scott Z, CESANO, Alessandra, GOLDENBERG, David M, KETAS, Jamie C, CHADBURN, Amy, FURMAN, Richard, SCHUSTER, Michael W, FELDMAN, Eric J, ASHE, Michelle, SCHUSTER, Stephen J, WEGENER, William A

Volltext

Epratuzumab: targeting B-cell malignancies through CD22 von Coleman, Morton, Goldenberg, David M, Siegel, Abby B, Ketas, Jamie C, Ashe, Michelle, Fiore, Jennifer M, Leonard, John P

Volltext

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma von Leonard, John P., Coleman, Morton, Ketas, Jamie C., Chadburn, Amy, Furman, Richard, Schuster, Michael W., Feldman, Eric J., Ashe, Michelle, Schuster, Stephen J., Wegener, William A., Hansen, Hans J., Ziccardi, Heather, Eschenberg, Michael, Gayko, Urte, Fields, Scott Z., Cesano, Alessandra, Goldenberg, David M.

Volltext

Epratuzumab von Morton Coleman, David M. Goldenberg, Abby B. Siegel, Jamie C. Ketas, Michelle Ashe, Jennifer M. Fiore, John P. Leonard

Volltext

Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma von LEONARD, John P, COLEMAN, Morton, KOVACS, Jacqueline, DING, Cliff L, WEGENER, William A, HORAK, Ivan D, GOLDENBERG, David M, KETAS, Jamie, ASHE, Michelle, FIORE, Jennifer M, FURMAN, Richard R, NIESVIZKY, Ruben, SHORE, Tsiporah, CHADBURN, Amy, HOME, Heather

Volltext

A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor von Trkola, A, Matthews, J, Gordon, C, Ketas, T, Moore, J P

Volltext

The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That... von Trkola, A, Gordon, C, Matthews, J, Maxwell, E, Ketas, T, Czaplewski, L, Proudfoot, A E, Moore, J P

Volltext